In order to determine the differences of Nrf2 mRNA expression in human glioma cell lines and normal brain tissues, the low grade glioma cell line, LN229, and WHO grade IV glioma cell lines, U87MG and GBM8401, were applied to perform quantitative RT-PCR. The gene discussed is NFE2L2; the disease is central nervous system cancer.